US 11135283
Retroviral vector for the administration and expression of replicon RNA expressing heterologous nucleic acids
granted A61KA61K39/21A61P
Quick answer
US patent 11135283 (Retroviral vector for the administration and expression of replicon RNA expressing heterologous nucleic acids) held by IMMUNE DESIGN CORP. expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- IMMUNE DESIGN CORP.
- Grant date
- Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K39/21, A61P, A61P31/12